Navigation Links
Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities
Date:3/13/2013

DUBLIN, March 13, 2013 /PRNewswire/ --

Research and Markets announces the addition of Greystone Associate's report "Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities" to its catalogue.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Driven by advances in molecular probe design and biomarker detection methodologies, new imaging agents that can improve visualization of pathologies and cellular processes are changing the practice of diagnostic medicine. The ability of this new generation of contrast agents to detect metabolic changes at the molecular level has significant potential for improving visualization and quality of care. Targetable and activatable imaging agents are gaining interest for a wide range of diagnostic applications that include cardiology, neurology and soft tissue tumor detection. The number of healthcare conditions that can be effectively imaged noninvasively is expanding as a result of these innovative detection technologies. Targeted and activatable imaging agents offer a unique capability to generate unambiguous images by exploiting specific molecular targets, pathways or cellular processes. This new wave of imaging agents signals a paradigm shift in which the reagents take on new importance.

Publication Overview

This market research report...

- analyzes and assesses emerging imaging diagnostic candidates, their capabilities, benefits, limitations and potential

- profiles development-stage imaging agents and examines their clinical status and commercial prospects

- analyzes key industry alliances and partnerships by imaging modality, and examines the impact of next-generation imaging candidates on future imaging markets

- profiles market participants, their development activity and business strategies

- evaluates the impact of economic, technology, and regulatory factors on the development and commercialization of emerging imaging agents

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contact Details

Research and Markets
Laura Wood , Senior Manager.
press(at)researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Diagnostics


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. UTSW molecular biologist Olson wins March of Dimes developmental biology prize
2. Researchers find molecular switch turning on self-renewal of liver damage
3. Denmark joins the Nordic EMBL Partnership for Molecular Medicine
4. Antibacterial proteins molecular workings revealed
5. Scientists identify molecular system that could help develop treatments for Alzheimers disease
6. Molecular basis identified for tissue specific immune regulation in the eye and kidney
7. Explosive breakthrough in research on molecular recognition
8. Mainz scientists confirm original tetrahedral model of the molecular structure of water
9. FASEB SRC announces: Molecular Mechanisms & Physiological Consequences of Protein Aggregation
10. FASEB SRC announces conference registration open for: Ciliate Molecular Biology
11. Elsevier launches new open access journal: Molecular Metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... and PUNE, India , January 19, 2017 /PRNewswire/ ... titled, "Global Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," the ... at a CAGR of 9.6% from 2016 to 2022. In 2015, ... to high-level security for both public and private sectors. ... ...
(Date:1/13/2017)... , Jan. 13, 2017 Sandata Technologies, ... for the homecare industry, including Electronic Visit Verification™ ... expert, Justin Jugs, as Senior Vice President of ... 15 years of homecare experience to Sandata, where ... strategic plans to align Sandata,s suite of solutions ...
(Date:1/11/2017)... Jan. 11, 2017 Intoxalock, a leading ignition ... release of its patent-pending calibration device. With this new ... calibrations, securely upload data logs and process repairs at ... "Fighting drunk driving through the application of ... at large, but also for the customer who can ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... 20, 2017 Aratana Therapeutics, Inc. (NASDAQ: ... the licensing, development and commercialization of innovative biopharmaceutical products ... Company in North America 2016. ... based on the FDA approval of three innovative ... ® (capromorelin oral solution) and NOCITA ® ...
(Date:1/20/2017)... 2017 http://www.Financialbuzz.com - ... leading causes of death worldwide. There were 8.2 million ... cancer related deaths increased gradually over time, the death ... of various cancers continues to drive demand of biological ... Global Market Insights, Inc. cancer biological therapy market size was ...
(Date:1/19/2017)... /PRNewswire -- WuXi AppTec, a leading global pharmaceutical, ... platform, today announced that it has acquired HD ... discovery contract research organization (CRO). After completion of ... of WuXi, and will continue to focus on ... The acquisition will further strengthen WuXi,s R&D capability ...
(Date:1/19/2017)... Jan. 19, 2017  ArmaGen, Inc., today announced ... Ph.D., as chief executive officer, as well as ... brings to ArmaGen more than 17 years of ... development of biotherapeutics and pharmaceuticals. ... diverse experience and skillset necessary to lead ArmaGen ...
Breaking Biology Technology: